CBD Archives - Green Market Report

Julie AitchesonJulie AitchesonDecember 6, 2019
skate-scaled.jpg

5min3170

Skateboarding has long been considered an “outlaw” sport on the recreational spectrum, attracting those for whom the structure and homogenous culture of organized athletics holds little appeal. Its anti-establishment origins, outlined in greater detail in this 2013 Skateboarding Magazine article, can be traced back to surfer culture, as wave riders realized there might be a way to surf city streets with the same élan and excitement that they applied to hanging ten in the water.

Both snowboarders and skateboarders have been associated with having a friendly relationship with cannabis. There is speculation that the original California high schoolers that met at 420 to get high, most likely rode on skateboards. Snowboarding’s admittance into the Olympics made many athletes ponder kipping the event if they had to give up smoking pot. The Olympics seemed to look the other way. Many professionals in both sports made no effort to hide their love of cannabis, which kept the rebellious nature of skateboarding intact.

But in recent years, skateboarding has moved away from the fringes and into the limelight with the popular X Games, an extreme sports event produced, hosted, and broadcast by ESPN, and demonstrated by the fact that skateboarding will be an official Olympic sport in Tokyo in 2020. This has given rise to some concern that the stereotype of the stoner skater will be proven true enough to keep some of the sport’s top athletes out of contention, as it did skateboarder Corey Juneau. Ranked seventh in the world, Juneau was suspended for six months after testing positive for THC in 2018.

As skateboarding’s competitiveness, popularity, and main street respectability grow, some of the sport’s biggest names are stepping out in front of companies that promise clean, potent, risk-free performance enhancement through CBD. Michael Apstein, a founding partner of Primary Growth Partners, says that “There is a long history of outlaw brands from other market segments breaking through to the general market – from surfing and skateboarding to extreme sports and certainly in music, apparel and recreation brands.” As the benefits of CBD gain visibility in all corners of the marketplace, skateboarding’s top athletes are endorsing products that provide low THC or THC-free alternatives to marijuana. Old school skateboarding legend Tony Hawk has even developed Birdhouse CBD Balm by producer Canna Hemp, a line of CBD recovery creams that target the epic aches and pains of the action sports market.

 

Professional skateboarder Andy McDonald, 23-time X Games medalist and 10-time world champion, recently partnered with CBD manufacturer Extract Labs to spread the word about the benefits of CBD for extreme sports athletes. McDonald, who used his platform as a professional skateboarder to take an anti-drug message all the way to the Clinton White House, credits the pain-alleviating benefits of hemp-derived CBD for helping him manage the cumulative effects of over 35 years of skating.

Social CBD, a company that markets a range of hemp-derived CBD products that guarantee a 0.0% THC content, recently hooked X-Games Skateboarding gold medalist Nyjah Huston as a spokesperson. Huston stakes his legacy as the winningest skateboarder in history on Social CBD’s promise to deliver a product pure enough to endure the scrutiny of the Olympic committee.

As skateboarding continues to move deeper into the mainstream of competitive sports, its shining stars will no doubt continue to seek out the healing benefits of CBD and the sponsorship dollars of those companies intent on making it the must-have, performance-enhancing supplement for extreme athletes.


Video StaffVideo StaffNovember 4, 2019

1min5600


Riley Cote is a Canadian former professional ice hockey left winger. Upon retiring from the Philadelphia Flyers Riley founded the Hemp Heals Foundation, a 501c3 non-profit organization that promotes cannabis/hemp as a viable renewable resource. Cote is a co-founder of Athletes For Care, a not-for-profit organization dedicated to creating a community where athletes can find support, opportunity, and purpose in life after a career in sports. Cote is currently launching a product line – BodyChek Wellness, a line of hemp-based personal care products whose mission is to optimize everyday performance and challenge individuals to rethink the healing process. The line reinforces Cote’s passion to help individuals discover safe nontoxic methods for pain management and self-healing.

This interview was conducted by Michael Miller of LA Weekly at the Green Market Summit in Los Angeles. Thank you for watching the Green Market Report! Be sure to subscribe to stay up to date with marijuana money.


Debra BorchardtDebra BorchardtOctober 22, 2019
cbd.jpg

4min6450
The U.S. Food and Drug Administration and the Federal Trade Commission posted a joint warning letter dated October 10, 2019 to Rooted Apothecary LLC, of Naples, Florida, for illegally selling unapproved products containing cannabidiol (CBD) online with unsubstantiated claims that the products treat teething pain and earaches in infants, autism, attention-deficit/hyperactivity disorder (ADHD), as well as Parkinson’s and Alzheimer’s disease, among other conditions or diseases.
The company used product webpages to make unfounded medical claims about its CBD products, and some of the products were also unlawfully marketed as dietary supplements. The agency has determined that CBD products cannot be marketed as dietary supplements.
The letter read, “The FDA has determined that your “Teeth/TMJ – Essential Oil + CBD Infusion,” “Ears – Essential Oil + CBD Infusion,” “Hemp Capsules, 750 mg,” “Hemp Infused Body Butter,” and “Hemp Oil” products are unapproved new drugs sold in violation of sections 505(a) and 301(d) of the Federal Food, Drug, and Cosmetic Act (the FD&C Act), 21 U.S.C. 355(a) and 331(d). Furthermore, these products are misbranded drugs under section 502(f)(1) of the FD&C Act, 21 U.S.C. 352(f)(1). “
The letter noted that “Adequate directions for use” means directions under which a layperson can use a drug safely and for the purposes for which it is intended. “Your products are offered for conditions that are not amenable to self-diagnosis and treatment by individuals who are not medical practitioners; therefore, adequate directions for use cannot be written so that a layperson can use these drugs safely for their intended purposes.”
It went on to say “It is unlawful under the FTC Act, 15 U.S.C. § 41 et seq., to advertise that a product can prevent, treat, or cure human disease unless you possess competent and reliable scientific evidence, including, when appropriate, well-controlled human clinical studies, substantiating that the claims are true at the time they are made.” The letter cited the product POM Wonderful, a pomegranate beverage that is suggested to be healthy.
The company has 15 days to correct its violations.

Debra BorchardtDebra BorchardtOctober 21, 2019
Kit_Jordans2.jpg

3min8111

2019 FIFA Women’s World Player of the Year, two-time Women’s World Cup champion and Olympic gold medalist, Megan Rapinoe will be sponsored by the women-owned sports recovery brand called Mendi

Designed with athletes in mind, Mendi’s first line of products is made with legal hemp CBD. Professional athletes can’t run the risk of registering positive results for trace amounts of THC  from a drug test. 

The statement said that Rapinoe would spearhead Mendi’s ‘Athlete Ambassador Program’ lending her voice and vision to amplify the brand’s presence. Rapinoe is expanding on her previous role with the group as a strategic partner and board advisors. The soccer star will be working with Mendi to find innovative ways to expand the athlete program so that more progressive standout players in other sports can be at the frontline advocating for player health and safety.  Megan’s valuable and growing role is a continuation of her entrepreneurial spirit and momentum she’s established with her twin sister, Rachael Rapinoe. 

“As a tool, CBD has been integral in Megan’s training and recovery program for the past few years,” said Rachael Rapinoe, CEO of Mendi. “She’s seen the massive potential for more people to adopt CBD into their recovery regimens and saw a need to do something about it by partnering with us to make sure we do it right.” 

Rapinoe catapulted to stardom as the women’s soccer team won the World Cup this year. The deal with Mendi is the first partnership she has announced with any brand since the World Cup. As an advocate for equal pay and inclusion, Megan wants this partnership to raise awareness of implementing diversity, inclusion, equal pay, equality, and justice into our communities and workplaces.

“By partnering with Mendi, we have the opportunity to work with Megan to make a difference and walk the walk,” said Rachael. “We’re not waiting for equal pay. It’s here today. We’re taking a proactive role to do something about it by building a business that cares for the athlete’s best interest and assembles our own team of industry vets that share these values and the passion to change the game for good. We’re building a brighter future for sports both on and off the field so we can pass the torch to the next generation of athletes.” 

Mendi currently offers three products, gel caps, gummies and a salve stick.


Debra BorchardtDebra BorchardtSeptember 17, 2019
cbd.jpg

4min4150
According to the U.S. Hemp Roundtable,  Majority Leader Mitch McConnell (R-KY) introduced language on the Agriculture Appropriations bill that would require the FDA to issue formal “enforcement discretion” on the sale of hemp CBD products.  The FDA had suggested it would take them 3-5 years to decide on rules and regulations for CBD.

The group’s website posted that the US Senate Appropriations Subcommittee on Agriculture will “mark up” language submitted by Senator McConnell that would require the FDA to formally stand down on any enforcement of its troublesome anti-CBD guidance. The notes are as follows:

  • Within 90 days, provide Congress a report outlining its efforts to develop an enforcement discretion policy on hemp CBD;

  • Within 120 days, issue its formal enforcement discretion policy on hemp CBD;

  • Keep the enforcement discretion policy in effect until the agency has implemented its final regulatory process; and

  • Ensure that going forward, CBD manufacturers would be able share safety data through existing FDA notification procedures to be fully compliant with federal law and policy.

The group also added that the bill will be marked up by the full Senate Appropriations Committee on Thursday, and could go to the full Senate soon. The Hemp Roundtable said that last week, Reps. Chellie Pingree (D-ME) and James Comer (R-KY) sent all members of the US House of Representatives a “Dear Colleague” letter, asking them to co-sign a letter that urges the FDA to issue formal “enforcement discretion” on the sale of hemp CBD products.

One of the biggest complaints following the passage of the 2018 Farm Bill that legalized hemp was that the product remained in a legal quagmire. Some states have outlawed hemp-derived CBD products, while others have no problems. Banks aren’t sure how to address CBD customers and even e-commerce has struggled with the issue. Shopify only just announced on Tuesday that it began working with CBD merchants, while Google refuses to allow CBD advertising.

The letter said, “However, FDA’s current regulatory approach on CBD has created significant regulatory
and legal uncertainty for participants in this quickly evolving industry. FDA maintains that food products
containing CBD remain illegal under the FDCA because it is the active ingredient in an epilepsy drug,
Epidiolex, that is undergoing clinical trials. Although the agency is exploring alternative regulatory
pathways, the FDA claims that a rulemaking process could take the agency anywhere between 3-5 years
to complete.”

 

 


Debra BorchardtDebra BorchardtSeptember 17, 2019
john-legend-201302-1-402.jpg

4min6820

(CSE: PLUS) (OTCQX: PLPRF) is kicking off a nationwide launch of its 100% hemp-derived CBD line and entertainer John Legend is partnering with the company. The celebrities joining the cannabis industry are getting bigger and brighter by the day.

“I have been a believer in the benefits of CBD for some time,” stated Legend. “I was drawn to the PLUS team because they’re an innovative, family-run company, and they use science to deliver a consistent, high-quality product. I appreciate that they’re committed to setting a high standard within an industry that has to date been fairly unregulated.”

PLUS is currently the number one and number two best-selling THC edibles in California, which is also the largest market for cannabis products. The new CBD line will include three distinct products, developed by PLUS’s team of scientists, entrepreneurs and chefs: BALANCE in Blueberry flavor, UPLIFT in Grapefruit flavor, and SLEEP in Blackberry Tea flavor.

PLUS Products Launches 100% Hemp CBD Edible Line

In addition to Legend, PLUS has also teamed with Casper Sleep Inc. to introduce its melatonin- and CBD-infused SLEEP product. “We’re always exploring new ways to improve sleep across the entire sleep arc — from sunset to sunrise,” said Neil Parikh, co-founder, and chief strategy officer at Casper. “Like PLUS, we believe sleep is a key part of the wellness equation. Partnering with their team of experts to introduce CBD sleep gummies brings a new way to relax and rest to those who need it.”

“We established our reputation in edibles by offering customers a consistent and precisely-dosed gummy using high-quality extracts,” stated Jake Heimark, CEO, and co-founder of PLUS. “Our CBD line will build off that expertise, and the earned trust we’ve established while offering a new experience for consumers designed to help them find their just right.”

“Giving the world a simple way to achieve balance has always been our mission, and the PLUS CBD line allows us to expand from California to nearly all fifty states overnight. We are thrilled that John Legend and Casper have partnered with our team to support this exciting new initiative.”

If you would like to learn more about the edible market, check out the new report from the Green Market Report titled, “The Economics of Edibles.”


Debra BorchardtDebra BorchardtSeptember 3, 2019
shutterstock_1093553171.jpg

3min17531

A new report from BDS Analytics titled “The Global Cannabinoids Market: Will CBD Overtake THC?” is forecasting that CBD sales will reach $20 billion by 2024. This would account for nearly 44%  of the $45 billion total forecasted
cannabinoid market (which includes legal cannabis).

Cannabidiol or CBD is a natural compound found within the cannabis plant. The report notes that CBD was first extracted from the cannabis plant in 1940, but it wasn’t until 1946 that Dr. Raphael Mechoulam identified the structure of CBD and later discovered properties within the compound to treat epilepsy. Since that time, the FDA approved the GW Pharmaceutical CBD drug Epidiolex for use in treating rare forms of epilepsy. Congress also passed the 2018 Farm Bill, which legalized help and set off a tsunami of hemp-derived CBD products onto the marketplace.

Last year, CBD sales hit $1.9 billion. BDS predicts that these sales will grow 49% annually. The report went on to say, “Further, sales of hemp-derived CBD (as opposed to CBD from marijuana) in U.S. general retail stores are expected to makeup $12.6 billion of the $20 billion in CBD sales forecast for 2024.”

The CBD market splits into two categories: the hemp-derived CBD that can be purchased just about anywhere and the CBD from marijuana that contains some amounts of THC. Many consumers believe the latter’s entourage capabilities are more effective. CBD sales in legal dispensaries rose from 3% in 2017 to 10% in 2018. BDS believes that as more mainstream consumers try CBD from hemp, they may be more disposed to going to a legal dispensary to try the marijuana-derived CBD.

The one drawback to the expected enormous growth of the CBD market is how the FDA plans on regulating the products in foods and beverages. The regulatory body has already cracked down on label claims forcing CVS Stores to remove Curaleaf products from its shelves. Hearings were held this past May with over 100 speakers offering their opinions. There is no timeline as to when the FDA will release a guideline as to how corporations and producers should act with regards to CBD products.

CBD Consumers

BDS Analytics Consumer Insights research revealed “That consumers primarily use CBD as a ‘natural’ remedy
for pain, stress, anxiety, and depression. Further, CBD consumers are divided 45% female, 55% male with an average age of 43, 40% are higher-educated and 50% are employed full-time.”

The top-selling CBD product categories are:

  1. Ingestibles     $883.5M
  2. Topicals          $491.2M
  3. Inhalables       $395.4M
  4. Pet Products   $63.8M
  5. Pharmaceuticals   $16.0M

Source: BDS Analytics Industry Intelligence

 


Anne-Marie FischerAnne-Marie FischerJuly 31, 2019
cbd5.jpg

8min53650

According to Brightfield Group, the CBD market in the U.S. has grown over 700% in 2019.

The CBD industry is becoming much more saturated than it was before the passing of the U.S. Farm Bill late last year, with new products entering the market, threatening to take a slice of the CBD pie that the early producers of CBD have enjoyed until this time.

Nevertheless, the top 20 CBD companies still hold a majority of the even bigger pie that is CBD in the cannabis industry. 

Brightfield Group listed the Top 5 CBD Companies that the research group says “continue to make a name for themselves” within the growing CBD market. Here’s what we know about these various companies:

 

  • CW Hemp (Charlotte’s Web)

 

Earlier this summer, Charlotte’s Web Holdings (TSX:CWEB)(OTCQX:CWBHF) announced that their total acres of hemp planted for the 2019 growing season had increased 187% due to interest and demand for the products. Prior to that, the company reported its earnings for the first quarter with revenue growing 66% to $21.7 million. 

“Interest and demand for our products has been exceptional and growing rapidly. Our 2019 planting strategy ensures we will have the required raw materials to deliver on production targets for Charlotte’s Web products through 2020 and into 2021,” stated Deanie Elsner, CEO of Charlotte’s Web. “Our leading CBD hemp varieties under cultivation today are the foundation of our 2020 production plan.”

Brightfield Group remarked of the company: “By deeply understanding who they are as a brand and identifying the consumers that resonate with their messaging, they have built the foundation for potentially life-long customers and advocates.”

  1. PlusCBD Oil (CV Sciences)

PlusCBD Oil by CV Sciences (OTCMKTS: CVSI) has found success largely due to their low-dose capsule and softgel formats that Brightfield Group referred to as “a safe bet for more conservative users”. Green Market Report has been watching the steady increase in CV Science’s company value following last year’s impressive sales jump of 203% in the second quarter. 

The company is expected to announce its second-quarter results for 2019 on August 6. 

        3. Green Roads World

Green Roads offers unique, high-dose products, and have built their success on effective social strategies. With a growing employee base of over 100 the company had an estimated value of $45 million in 2018, according to co-founder Arby Boroso. 

The company sells CBD-infused products such as tinctures and balms, online and in 6,000 stores and 2,000 doctors’ offices across the country. Brightfield attributes their “values-based marketing” to their success and prominence in the CBD industry. 

  1. Medterra

Medterra’s growth is largely due to its effective SEO strategy and marketing. With a site that is full of engaging content that manages to get past the limitations of search engines, Medterra gets itself in front of the eyes of consumers.

The company recently announced a foray into the sports, fitness and golf communities, by partnering with Worldwide Golf Shops, the parent company to Edwin Watts, Roger Dunn, and some of the most well-known and established golf retail stores in the United States. 

  1. Irwin Naturals

Irwin Naturals turned heads when Klee Irwin, the founder of the company announced the company would be giving away $1M worth of CBD products to honor the passing of the Farm Bill. 

The company is concerned with making the cost of CBD products affordable, saying “Our mission is to spread health to the world through plant medicine. Our nation is on the edge. And I am worried about the future of our children. If we can make CBD affordable and accessible to the masses, it just might help our country avoid a meltdown.”

Groups of Competitors in the CBD Market

Brightfield Group laid out the different types of companies and brands that are continuing to lead the pack when it comes to innovative marketing, advanced products, and ways to stick out in the market. These companies are those who are:

  • CBD-only companies that have established brand loyalty, improved marketing strategies, and grow larger and more diverse customer bases
  • Cannabis companies including multi-state operators that leverage networks and infrastructure to build brand recognition and raise capital to expand CBD lines
  • Supplement brands existing in the natural food store and retail chain space
  • Disruptor brands that were little-known prior to this year and have risen up in the ranks as they’ve been picked up by large retail chains

As it is only still summer, it remains anyone’s game as to who will end up at the finish line in the CBD brand race by the end of the year.  


StaffStaffJuly 29, 2019
shutterstock_1093553171.jpg

14min45470

Guest submission from Ivan Green.

Hundreds of people have been benefited from using Cannabidiol (CBD) – a substance scientifically proven to be safe for human consumption – even for children! 

It not only has a wide range of therapeutic benefits but also has been useful for treating numerous serious ailments and disorders. 

However, not all products touted as “natural CBD oil” are actually as natural they claim to be. 

Natural CBD is admittedly safe. But they don’t include products that are made from synthetic lab-produced cannabinoids or contain contaminants, high levels of hallucinatory cannabinoids like Tetrahydrocannabinol (THC) or other harmful substances. 

Using such products will do more damage to you than simply making you fail a drug test. You can end up falling horribly sick or even dead! 

With the growing popularity of CBD products, some unscrupulous cannabis growers and CBD oil manufacturers are taking advantage of loopholes in the existing regulations and the vulnerabilities of the common man in this country to push their business forward with cheap, artificial and untested products in the name of CBD oil. 

Cheap Synthetic CBD 

From a once non-existent market category to a $1 billion industry, the hemp-derived CBD has become a booming industry today. 

But, it was disheartening to hear of 50 people falling severely ill after using CBD oil in Utah last year. It is worse when we find out that the oil that those people unwittingly smoked up thinking it was genuine CBD vape oil did not even contain any natural cannabinoid, but contained some lab-produced synthetic cannabinoids

The reason why people fall for these products are usually because of three reasons: 

  1. Their low price, 
  2. Tall promises of curing all health conditions, and 
  3. Claims of not being detected on a drug test. 

The unfortunate thing is these people were plain and simple duped! The company lied to its customers, and as a result, harmed them in ways that their unwary consumers were not prepared for. 

These dangerous designer drugs had prompted the US Centers for Disease Control and Prevention (CDC) to issue a nationwide health warning about these man-made synthetic cannabinoids. 

This is precisely why most reputed brands who sell genuine products are obligated to present their proof of their genuineness to their customers. They post the results of their products tested by third-party laboratories, also known as a Certificate of Analysis, which tests not only for synthetic components, but also other contaminants like heavy metals and pesticides and heavy metals as well as natural cannabinoids that possess hallucinatory effects, like THC (tetrahydrocannabinol, a natural cannabinoid found in cannabis plants).

Spice 

Known by different names – K2, Spice, Mr. Happy, Scooby Snax, and Kronic – is nothing but a group of lab-made synthetic cannabinoids that have been associated with a lot of people falling sick.

Originally designed by scientists for research, this drug is made from dried plant materials, sprayed with hallucinogenic chemicals. 

However, with the production method of this drug being published in scientific journals as part of their research, this knowledge also fell into the hands of some unscrupulous, over-ambitious drug makers, who used it to produce illicit drugs.

Once it hit the market, it came out as a new form of marijuana and people started rolling up the plant material into “joints” and smoking them like marijuana. 

This synthetic marijuana or fake weed is also sold in a liquid form that can be inhaled through a vape pen or mixed in tea to consume. 

Although these are man-made cannabinoids, it has the same effect on the human brain (especially the endocannabinoid system) as THC, but with far more intensity (even up to 100 times more intense). 

With no way to regulate them, there is no saying which hallucinogens are being used by the manufacturers to make their products.

The “Free” Scam 

Nothing in the CBD world is free. It simply can’t be. Manufacturing a bottle of genuine, natural CBD oil is expensive. If anybody tells you otherwise, be sure you are being tricked. 

While searching for CBD oil online, if you come across phrases like: 

  • Best Price, Limited Offer
  • Limited-Time Special Offer 
  • Special Discount For Only Today

Then be alert. Look up the brand and find out if their products are genuine. 

And if you see:

  • CBD oil free trial 
  • Or, they tell you to submit your credit card to free stuff 

DON’T BUY, REPORT. 

Some “free sample” offers are nothing more than hidden subscription ploy to force you to give away your credit/debit card details, which they will use to forcefully sell you low-quality products. You may even find it difficult to cancel the alleged subscription. You may have to call up your bank or credit card company to cancel their card to stop payments. 

Some other scammers will charge you more for what they are selling by simply calling it shipping and processing fee (while they send you a low-quality product). 

Quite a few reputed CBD brands offer quality products at a fair price. Do due diligence while looking for a CBD product and research on their makers. Find out everything you can about a company and the brand before you blindly fall for such “Free, Free, Free” lure. 

Pushing Hemp Seed Oil Instead of Hemp CBD 

Another reason for the confusion among users and abuse of the market is ignorance. Not only do you need to be wary about “fake CBD” and “free samples”, but you should also learn everything there is to know about how CBD is sourced and manufactured. 

If you have, you would know that hemp seed oil is not CBD oil derived from hemp. 

So, when you research on any brand, look for its ingredients on the label or their website. 

If it is Hempseed Oil, it will be listed as Cannabis Sativa Seed Oil.

If it is genuine CBD oil, you may see Cannabidiol, full-spectrum hemp, hemp oil, PCR (phytocannabinoid-rich) or PCR hemp extracts written on the label.

Also, look at their CoA for their products on their product webpages. 

Yes, they are lab tests, but not difficult for a layman to read and understand. It is meant for you, so it’s really quite simple. 

Hemp seed oil: Although a good carrier oil for CBD, it is not the same as CBD oil. So what is it? 

For that, you need to know where CBD oil is sourced. The best quality and most potent CBD oils are produced from hemp flowers. While the rest of the plant – like its leaves and shoots – may be used too. But, they have far less CBD content. 

The smaller seeds, in particular, have the least amount of it – traces at the best. Hemp seeds can be used to make hempseed milk or granola. They can also be cold-pressed to produce oil. But this oil is only good for cooking, making beauty products, or making paint. 

While hemp seed oil does have some benefits, like mild anti-inflammatory effects and skin moisturizer, it does not have sufficient levels of CBD to be called “CBD oil”. 

This means you would end up paying much for the product that it deserves. Intentionally or unintentionally, some companies try to push a cheaper product like hemp seed oil. 

Tricking Consumers with Products with low CBD content

Apart from hemp seed oil, there are other CBD products that don’t contain enough CBD to have any perceivable health benefits. 

Always look for the CBD content in mg on the label. This is the concentration of the CBD contained in the product. The total volume of the liquid does not guarantee CBD content. 

For instance, a 3 oz. bottle of tincture, priced at $50 and containing only 100 mg of CBD, may seem like a good deal. But, it is actually not. It is costing you $0.50/mg. A 1 oz. bottle, priced at $132 and containing 3000mg of CBD, is, in fact, a better deal ($0.04/mg). 

Making Sure You Get Quality Product 

By now, you must have understood that buying CBD oil isn’t as easy as you may have thought – click-click-click. 

You need to do a lot of research…

  • Research on how CBD oil is sourced, extracted, processed, purified, and the end product manufactured. 
  • Research on the companies and brands selling the products
  • Studying the CoAs, if they are provided by the companies. If they are not provided, they are obligated to provide one on request. 
  • Understanding the current market situation and the presence of synthetic cannabinoids, scammers, and cheap variants with tall claims.
  • The actual health benefits of CBD, so you don’t get lured by brands that make outrageous claims like curing cancer! 

Always make sure you get a high-quality CBD product when you place your order. Never let promotions, discounts or unrealistic claims fool you. 

When it comes to buying CBD, there is no bliss in ignorance, only suffering!


Anne-Marie FischerAnne-Marie FischerJuly 12, 2019
shutterstock_1093553171.jpg

5min23760

According to a recent Headset market report, “Understanding the CBD market in state-legal cannabis”, CBD could potentially take up the majority of sales among non-inhalable products in legal cannabis states. If current trends continue, CBD products could even potentially become the majority of sales among the cannabis industry at large.

The data giant revealed insights into the shift in popularity and sales for CBD products, noting the passage of the U.S. Farm Bill as an important catalyst for allowing more people to access cannabis products. The report is quick to note that despite going into the mainstream, hemp-derived CBD products (now purchased at places like CVS Health Corporation (NYSE: CVS) and Walgreens) and cannabis-derived CBD products (traditionally purchased at dispensaries) are to be considered two different things.

Here are some important highlights of the Headset market report that Green Market Report finds of interest:

Google Searches for CBD

The Headset report reaches back to 2015, citing data from Google searches for CBD. At the start of that year, Google searches for CBD were nil. Google searches for CBD were at an all-time spike in May of 2019, representing a 100% increase of when CBD first hit the Google searches later in 2015.

A Non-Smoking Experience

While the cannabis industry is characterized by smoking and inhaling cannabis products like traditional cannabis buds or flower and concentrates, the CBD trends are showing that one-third of CBD sales are going to non-inhalable products. Customers are demonstrating a preference for edibles, topicals, tinctures, and sublinguals. Headset suggests that “the CBD market is expanding on top of the existing market for high-THC, psychoactive inhalable products, rather than inside it.”

The report also states that there is a “new and distinct customer base” that is more health-conscious, preferring to stay away from pre-roll and vapor pen products. 

CBD Product Categories

Within the non-inhalable CBD products category, Headset compiled data from Washington and Colorado and saw that there are 5 emerging product categories: Beverages, Capsules, Edibles, Topicals, and Tinctures & Sublinguals. 

CBD products have experienced a surge in growth in the past 12 months in comparison to tradition, THC-based products. 

CBD Edibles have always had the highest market share and retains this position, with customers gravitating to high CBD products. CBD Edibles experienced a 43.9% growth this year, compared to 24.8% growth for non-CBD edible products. Almost 50% of dollars spent on all edibles in 2019 were spent on CBD Gummies. Within the edible product category, honey, sugar, and sweeteners, CBD products made up almost 1/3 of the proportion of overall sales. 

Capsules are not showing much growth in the overall product categories. Headset speculates that this is because capsules are “usually associated with medical conditions” and that CBD is used as therapy rather than a full-on medication.

Tinctures and Topicals & Sublinguals are the dark horse of the CBD market, once having just a tiny sliver, and now taking a giant slice, growing nearly 60% in sales in the past 12 months in comparison to high-THC infused products’ 10% increase.

Headset suggests that “if your company is producing Gummies, but not CBD Gummies, you may want to adjust course”.

Opening Wallets for CBD

Average item price (AIP) and the number of products people are adding to their basket in the CBD category (basket penetration) are rising concurrently.

Since 2015, CBD went from only 3% of baskets to 7% in 2019. Average item price also is rising with the interest in CBD, indicating that “consumers aren’t only more interested in CBD, but also more willing to spend money on it”. 

 



About Us

The Green Market Report focuses on the financial news of the rapidly growing cannabis industry. Our target approach filters out the daily noise and does a deep dive into the financial, business and economic side of the cannabis industry. Our team is cultivating the industry’s critical news into one source and providing open source insights and data analysis


READ MORE



Recent Tweets

@GreenMarketRpt – 1 day

Our biggest fans this week: WallandBroad, IMITAKCO, Gambiste1. Thank you! via

@GreenMarketRpt – 2 days

My week on Twitter 🎉: 1 Mention, 823 Mention Reach, 4 Likes, 7 Retweets, 29K Retweet Reach. See yours with…

@GreenMarketRpt – 2 days

Our biggest fans this week: WallandBroad, IMITAKCO, Gambiste1. Thank you! via

Back to Top

You have Successfully Subscribed!